ישראל - עברית - Ministry of Health

teva israel ltd - amiloride as hydrochloride anhydrous; hydrochlorothiazide - טבליה - amiloride as hydrochloride anhydrous 5 mg; hydrochlorothiazide 50 mg - hydrochlorothiazide and potassium-sparing agents

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - amiloride as hydrochloride 5 mg; hydrochlorothiazide 50 mg - tablets - hydrochlorothiazide and potassium-sparing agents - hypertension: kaluril is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of the disease. edema: edema associated with congestive heart failure and hepatic cirrhosis.

ישראל - עברית - Ministry of Health

sanofi israel ltd - hydrochlorothiazide; ramipril - טבליה - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

ישראל - עברית - Ministry of Health

sanofi israel ltd - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

ישראל - עברית - Ministry of Health

naomi shaco-ezra ltd - buprenorphine as hydrochloride; naloxone as hydrochloride dihydrate - buprenorphine as hydrochloride 4 mg; naloxone as hydrochloride dihydrate 1 mg - buprenorphine

ישראל - עברית - Ministry of Health

naomi shaco-ezra ltd - buprenorphine as hydrochloride; naloxone as hydrochloride dihydrate - buprenorphine as hydrochloride 12 mg; naloxone as hydrochloride dihydrate 3 mg - buprenorphine

ישראל - עברית - Ministry of Health

naomi shaco-ezra ltd - buprenorphine as hydrochloride; naloxone as hydrochloride dihydrate - buprenorphine as hydrochloride 2 mg; naloxone as hydrochloride dihydrate 0.5 mg - buprenorphine

ישראל - עברית - Ministry of Health

naomi shaco-ezra ltd - buprenorphine as hydrochloride; naloxone as hydrochloride dihydrate - buprenorphine as hydrochloride 8 mg; naloxone as hydrochloride dihydrate 2 mg - buprenorphine

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - metformin hydrochloride; pioglitazone as hydrochloride - טבליות מצופות פילם - metformin hydrochloride 850 mg; pioglitazone as hydrochloride 15 mg - metformin - metformin - competact is indicated as second line treatment of type 2 diabetes mellitus adult patients,particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.after initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in hba1c). in patients who fail to show an adequate response, pioglitazone should be discontinued. in light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - lidocaine as hydrochloride; methylprednisolone acetate - תרחיף להזרקה - lidocaine as hydrochloride 10 mg/ml; methylprednisolone acetate 40 mg/ml - methylprednisolone, combinations - lidocaine - depo-medrol with lidocaine is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: - synovitis of osteoarthritis - rheumatoid arthritis - acute and subacute bursitis - acute gouty arthritis - epicondylitis - acute nonspecific tenosynovitis - post-traumatic osteoarthritis.